nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP11A1—polycystic ovary syndrome	0.519	0.724	CbGaD
Omeprazole—CYP1A1—polycystic ovary syndrome	0.197	0.276	CbGaD
Omeprazole—CYP11A1—corpus luteum—polycystic ovary syndrome	0.0188	0.212	CbGeAlD
Omeprazole—Vitamin B12 deficiency—Metformin—polycystic ovary syndrome	0.0152	0.207	CcSEcCtD
Omeprazole—CYP11A1—ovarian follicle—polycystic ovary syndrome	0.0147	0.166	CbGeAlD
Omeprazole—ATP4B—endocrine gland—polycystic ovary syndrome	0.00357	0.0402	CbGeAlD
Omeprazole—CYP2C19—urine—polycystic ovary syndrome	0.00327	0.0369	CbGeAlD
Omeprazole—CYP1A2—urine—polycystic ovary syndrome	0.00267	0.0301	CbGeAlD
Omeprazole—CYP2C9—urine—polycystic ovary syndrome	0.00254	0.0286	CbGeAlD
Omeprazole—ATP4A—adrenal cortex—polycystic ovary syndrome	0.00248	0.028	CbGeAlD
Omeprazole—Fungal infection—Metformin—polycystic ovary syndrome	0.00206	0.0282	CcSEcCtD
Omeprazole—Rigors—Metformin—polycystic ovary syndrome	0.00195	0.0267	CcSEcCtD
Omeprazole—CYP3A4—urine—polycystic ovary syndrome	0.00194	0.0218	CbGeAlD
Omeprazole—CYP2D6—urine—polycystic ovary syndrome	0.00191	0.0215	CbGeAlD
Omeprazole—Accidental injury—Metformin—polycystic ovary syndrome	0.0018	0.0246	CcSEcCtD
Omeprazole—ATP4A—adrenal gland—polycystic ovary syndrome	0.00179	0.0202	CbGeAlD
Omeprazole—CYP11A1—adrenal cortex—polycystic ovary syndrome	0.00163	0.0183	CbGeAlD
Omeprazole—ATP4A—endocrine gland—polycystic ovary syndrome	0.00155	0.0175	CbGeAlD
Omeprazole—Lightheadedness—Metformin—polycystic ovary syndrome	0.00143	0.0195	CcSEcCtD
Omeprazole—CYP2C18—vagina—polycystic ovary syndrome	0.00137	0.0154	CbGeAlD
Omeprazole—Ear pain—Metformin—polycystic ovary syndrome	0.00136	0.0185	CcSEcCtD
Omeprazole—CYP11A1—adipose tissue—polycystic ovary syndrome	0.00131	0.0148	CbGeAlD
Omeprazole—CYP2C18—endocrine gland—polycystic ovary syndrome	0.00128	0.0144	CbGeAlD
Omeprazole—ABCC3—adrenal cortex—polycystic ovary syndrome	0.00126	0.0142	CbGeAlD
Omeprazole—Injury—Metformin—polycystic ovary syndrome	0.00126	0.0172	CcSEcCtD
Omeprazole—Renal impairment—Metformin—polycystic ovary syndrome	0.00122	0.0166	CcSEcCtD
Omeprazole—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00119	0.0162	CcSEcCtD
Omeprazole—CYP11A1—adrenal gland—polycystic ovary syndrome	0.00118	0.0132	CbGeAlD
Omeprazole—Pain in extremity—Metformin—polycystic ovary syndrome	0.00116	0.0158	CcSEcCtD
Omeprazole—Migraine—Metformin—polycystic ovary syndrome	0.00114	0.0156	CcSEcCtD
Omeprazole—CYP11A1—female gonad—polycystic ovary syndrome	0.0011	0.0123	CbGeAlD
Omeprazole—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00106	0.0144	CcSEcCtD
Omeprazole—Breast disorder—Metformin—polycystic ovary syndrome	0.00105	0.0143	CcSEcCtD
Omeprazole—Cramp muscle—Metformin—polycystic ovary syndrome	0.00104	0.0142	CcSEcCtD
Omeprazole—CYP11A1—endocrine gland—polycystic ovary syndrome	0.00102	0.0115	CbGeAlD
Omeprazole—ABCC3—adipose tissue—polycystic ovary syndrome	0.00102	0.0115	CbGeAlD
Omeprazole—Abdominal distension—Metformin—polycystic ovary syndrome	0.00101	0.0137	CcSEcCtD
Omeprazole—Influenza—Metformin—polycystic ovary syndrome	0.001	0.0137	CcSEcCtD
Omeprazole—Pancreatitis—Metformin—polycystic ovary syndrome	0.00098	0.0134	CcSEcCtD
Omeprazole—Sweating increased—Metformin—polycystic ovary syndrome	0.000974	0.0133	CcSEcCtD
Omeprazole—Angina pectoris—Metformin—polycystic ovary syndrome	0.000974	0.0133	CcSEcCtD
Omeprazole—Rabeprazole—CYP1A1—polycystic ovary syndrome	0.000951	0.573	CrCbGaD
Omeprazole—Neutropenia—Metformin—polycystic ovary syndrome	0.000935	0.0128	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000929	0.0127	CcSEcCtD
Omeprazole—ABCC3—adrenal gland—polycystic ovary syndrome	0.000912	0.0103	CbGeAlD
Omeprazole—Infestation NOS—Metformin—polycystic ovary syndrome	0.000891	0.0122	CcSEcCtD
Omeprazole—Infestation—Metformin—polycystic ovary syndrome	0.000891	0.0122	CcSEcCtD
Omeprazole—ABCC3—female gonad—polycystic ovary syndrome	0.00085	0.00958	CbGeAlD
Omeprazole—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000843	0.0115	CcSEcCtD
Omeprazole—Bradycardia—Metformin—polycystic ovary syndrome	0.000815	0.0111	CcSEcCtD
Omeprazole—CYP1B1—uterus—polycystic ovary syndrome	0.000814	0.00917	CbGeAlD
Omeprazole—Rhinitis—Metformin—polycystic ovary syndrome	0.000802	0.011	CcSEcCtD
Omeprazole—Hepatitis—Metformin—polycystic ovary syndrome	0.0008	0.0109	CcSEcCtD
Omeprazole—CYP1B1—pituitary gland—polycystic ovary syndrome	0.000799	0.009	CbGeAlD
Omeprazole—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000796	0.0109	CcSEcCtD
Omeprazole—CYP1B1—adipose tissue—polycystic ovary syndrome	0.000796	0.00896	CbGeAlD
Omeprazole—ABCC3—endocrine gland—polycystic ovary syndrome	0.000791	0.00891	CbGeAlD
Omeprazole—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000788	0.0108	CcSEcCtD
Omeprazole—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000786	0.0107	CcSEcCtD
Omeprazole—Eye disorder—Metformin—polycystic ovary syndrome	0.000748	0.0102	CcSEcCtD
Omeprazole—Flushing—Metformin—polycystic ovary syndrome	0.000743	0.0101	CcSEcCtD
Omeprazole—ABCG2—adrenal cortex—polycystic ovary syndrome	0.000736	0.00829	CbGeAlD
Omeprazole—Immune system disorder—Metformin—polycystic ovary syndrome	0.000723	0.00987	CcSEcCtD
Omeprazole—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000721	0.00985	CcSEcCtD
Omeprazole—Chills—Metformin—polycystic ovary syndrome	0.000718	0.00981	CcSEcCtD
Omeprazole—CYP1B1—adrenal gland—polycystic ovary syndrome	0.000714	0.00804	CbGeAlD
Omeprazole—Lansoprazole—CYP1A1—polycystic ovary syndrome	0.000709	0.427	CrCbGaD
Omeprazole—Malnutrition—Metformin—polycystic ovary syndrome	0.000697	0.00951	CcSEcCtD
Omeprazole—Flatulence—Metformin—polycystic ovary syndrome	0.000686	0.00938	CcSEcCtD
Omeprazole—Dysgeusia—Metformin—polycystic ovary syndrome	0.000682	0.00932	CcSEcCtD
Omeprazole—CYP2C8—endometrium—polycystic ovary syndrome	0.000676	0.00762	CbGeAlD
Omeprazole—Muscle spasms—Metformin—polycystic ovary syndrome	0.00067	0.00915	CcSEcCtD
Omeprazole—CYP1B1—female gonad—polycystic ovary syndrome	0.000665	0.0075	CbGeAlD
Omeprazole—ABCG2—endometrium—polycystic ovary syndrome	0.000657	0.00741	CbGeAlD
Omeprazole—Vision blurred—Metformin—polycystic ovary syndrome	0.000656	0.00897	CcSEcCtD
Omeprazole—Tremor—Metformin—polycystic ovary syndrome	0.000653	0.00891	CcSEcCtD
Omeprazole—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000646	0.00883	CcSEcCtD
Omeprazole—Malaise—Metformin—polycystic ovary syndrome	0.000628	0.00858	CcSEcCtD
Omeprazole—CYP1B1—endocrine gland—polycystic ovary syndrome	0.000619	0.00697	CbGeAlD
Omeprazole—Palpitations—Metformin—polycystic ovary syndrome	0.000616	0.00841	CcSEcCtD
Omeprazole—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000612	0.00689	CbGeAlD
Omeprazole—ABCG2—uterus—polycystic ovary syndrome	0.000606	0.00683	CbGeAlD
Omeprazole—Hypertension—Metformin—polycystic ovary syndrome	0.000601	0.00821	CcSEcCtD
Omeprazole—ABCG2—pituitary gland—polycystic ovary syndrome	0.000595	0.0067	CbGeAlD
Omeprazole—Chest pain—Metformin—polycystic ovary syndrome	0.000593	0.0081	CcSEcCtD
Omeprazole—Myalgia—Metformin—polycystic ovary syndrome	0.000593	0.0081	CcSEcCtD
Omeprazole—ABCG2—adipose tissue—polycystic ovary syndrome	0.000592	0.00668	CbGeAlD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000589	0.00804	CcSEcCtD
Omeprazole—Discomfort—Metformin—polycystic ovary syndrome	0.000586	0.008	CcSEcCtD
Omeprazole—CYP2C19—vagina—polycystic ovary syndrome	0.00058	0.00654	CbGeAlD
Omeprazole—CYP1A1—uterus—polycystic ovary syndrome	0.000575	0.00648	CbGeAlD
Omeprazole—Infection—Metformin—polycystic ovary syndrome	0.000565	0.00771	CcSEcCtD
Omeprazole—CYP1A1—adipose tissue—polycystic ovary syndrome	0.000562	0.00634	CbGeAlD
Omeprazole—Shock—Metformin—polycystic ovary syndrome	0.000559	0.00764	CcSEcCtD
Omeprazole—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000557	0.00762	CcSEcCtD
Omeprazole—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000557	0.0076	CcSEcCtD
Omeprazole—Skin disorder—Metformin—polycystic ovary syndrome	0.000552	0.00754	CcSEcCtD
Omeprazole—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00055	0.00751	CcSEcCtD
Omeprazole—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000543	0.00612	CbGeAlD
Omeprazole—Anorexia—Metformin—polycystic ovary syndrome	0.000542	0.0074	CcSEcCtD
Omeprazole—ABCG2—adrenal gland—polycystic ovary syndrome	0.000531	0.00599	CbGeAlD
Omeprazole—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000518	0.00707	CcSEcCtD
Omeprazole—Paraesthesia—Metformin—polycystic ovary syndrome	0.00051	0.00697	CcSEcCtD
Omeprazole—Dyspnoea—Metformin—polycystic ovary syndrome	0.000507	0.00692	CcSEcCtD
Omeprazole—CYP2C8—vagina—polycystic ovary syndrome	0.000507	0.00571	CbGeAlD
Omeprazole—Somnolence—Metformin—polycystic ovary syndrome	0.000505	0.0069	CcSEcCtD
Omeprazole—Dyspepsia—Metformin—polycystic ovary syndrome	0.0005	0.00684	CcSEcCtD
Omeprazole—ABCG2—female gonad—polycystic ovary syndrome	0.000496	0.00558	CbGeAlD
Omeprazole—Decreased appetite—Metformin—polycystic ovary syndrome	0.000494	0.00675	CcSEcCtD
Omeprazole—ABCG2—vagina—polycystic ovary syndrome	0.000493	0.00555	CbGeAlD
Omeprazole—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000491	0.0067	CcSEcCtD
Omeprazole—Fatigue—Metformin—polycystic ovary syndrome	0.00049	0.00669	CcSEcCtD
Omeprazole—Constipation—Metformin—polycystic ovary syndrome	0.000486	0.00664	CcSEcCtD
Omeprazole—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000474	0.00534	CbGeAlD
Omeprazole—CYP1A1—female gonad—polycystic ovary syndrome	0.00047	0.0053	CbGeAlD
Omeprazole—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000468	0.0064	CcSEcCtD
Omeprazole—CYP1A1—vagina—polycystic ovary syndrome	0.000468	0.00527	CbGeAlD
Omeprazole—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000465	0.00635	CcSEcCtD
Omeprazole—Urticaria—Metformin—polycystic ovary syndrome	0.000452	0.00617	CcSEcCtD
Omeprazole—Abdominal pain—Metformin—polycystic ovary syndrome	0.000449	0.00614	CcSEcCtD
Omeprazole—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000444	0.005	CbGeAlD
Omeprazole—ABCB1—embryo—polycystic ovary syndrome	0.000443	0.00499	CbGeAlD
Omeprazole—CYP1A1—endocrine gland—polycystic ovary syndrome	0.000438	0.00493	CbGeAlD
Omeprazole—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000421	0.00474	CbGeAlD
Omeprazole—Asthenia—Metformin—polycystic ovary syndrome	0.000408	0.00557	CcSEcCtD
Omeprazole—Pruritus—Metformin—polycystic ovary syndrome	0.000402	0.00549	CcSEcCtD
Omeprazole—Diarrhoea—Metformin—polycystic ovary syndrome	0.000389	0.00531	CcSEcCtD
Omeprazole—Dizziness—Metformin—polycystic ovary syndrome	0.000376	0.00513	CcSEcCtD
Omeprazole—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000363	0.00409	CbGeAlD
Omeprazole—Vomiting—Metformin—polycystic ovary syndrome	0.000361	0.00494	CcSEcCtD
Omeprazole—Rash—Metformin—polycystic ovary syndrome	0.000358	0.0049	CcSEcCtD
Omeprazole—Dermatitis—Metformin—polycystic ovary syndrome	0.000358	0.00489	CcSEcCtD
Omeprazole—Headache—Metformin—polycystic ovary syndrome	0.000356	0.00486	CcSEcCtD
Omeprazole—CYP2D6—female gonad—polycystic ovary syndrome	0.00034	0.00383	CbGeAlD
Omeprazole—Nausea—Metformin—polycystic ovary syndrome	0.000338	0.00461	CcSEcCtD
Omeprazole—ABCB1—endometrium—polycystic ovary syndrome	0.000324	0.00365	CbGeAlD
Omeprazole—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000321	0.00362	CbGeAlD
Omeprazole—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000316	0.00356	CbGeAlD
Omeprazole—ABCB1—uterus—polycystic ovary syndrome	0.000299	0.00337	CbGeAlD
Omeprazole—ABCB1—pituitary gland—polycystic ovary syndrome	0.000293	0.00331	CbGeAlD
Omeprazole—ABCB1—adipose tissue—polycystic ovary syndrome	0.000292	0.00329	CbGeAlD
Omeprazole—ABCB1—adrenal gland—polycystic ovary syndrome	0.000262	0.00295	CbGeAlD
Omeprazole—ABCB1—female gonad—polycystic ovary syndrome	0.000244	0.00275	CbGeAlD
Omeprazole—ABCB1—vagina—polycystic ovary syndrome	0.000243	0.00274	CbGeAlD
Omeprazole—ABCB1—endocrine gland—polycystic ovary syndrome	0.000227	0.00256	CbGeAlD
Omeprazole—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.6e-05	0.000134	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	1.6e-05	0.000133	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	1.59e-05	0.000133	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.58e-05	0.000132	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.58e-05	0.000132	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—NCOR1—polycystic ovary syndrome	1.56e-05	0.00013	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—STAR—polycystic ovary syndrome	1.56e-05	0.00013	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.56e-05	0.00013	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.55e-05	0.00013	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	1.54e-05	0.000128	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	1.53e-05	0.000127	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—TH—polycystic ovary syndrome	1.52e-05	0.000127	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CYP1A1—polycystic ovary syndrome	1.52e-05	0.000127	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	1.52e-05	0.000127	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—LHB—polycystic ovary syndrome	1.51e-05	0.000126	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.5e-05	0.000125	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.49e-05	0.000124	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.49e-05	0.000124	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—SLC2A4—polycystic ovary syndrome	1.48e-05	0.000124	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CYP1A1—polycystic ovary syndrome	1.48e-05	0.000124	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	1.48e-05	0.000123	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	1.47e-05	0.000122	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	1.46e-05	0.000121	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.44e-05	0.00012	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	1.43e-05	0.000119	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.42e-05	0.000119	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	1.42e-05	0.000119	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—MTHFR—polycystic ovary syndrome	1.42e-05	0.000118	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CYP19A1—polycystic ovary syndrome	1.39e-05	0.000116	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.39e-05	0.000116	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.39e-05	0.000116	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—TH—polycystic ovary syndrome	1.39e-05	0.000116	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	1.39e-05	0.000116	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—MTHFR—polycystic ovary syndrome	1.38e-05	0.000115	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	1.38e-05	0.000115	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	1.36e-05	0.000113	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	1.36e-05	0.000113	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	1.35e-05	0.000112	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.34e-05	0.000112	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PPARG—polycystic ovary syndrome	1.33e-05	0.000111	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.32e-05	0.00011	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	1.32e-05	0.00011	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—POMC—polycystic ovary syndrome	1.31e-05	0.00011	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	1.31e-05	0.000109	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	1.31e-05	0.000109	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.31e-05	0.000109	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—INS—polycystic ovary syndrome	1.31e-05	0.000109	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	1.3e-05	0.000109	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	1.3e-05	0.000108	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	1.28e-05	0.000106	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.27e-05	0.000106	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	1.27e-05	0.000106	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.27e-05	0.000106	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.27e-05	0.000106	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	1.25e-05	0.000104	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GNAS—polycystic ovary syndrome	1.24e-05	0.000104	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	1.24e-05	0.000104	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	1.24e-05	0.000103	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	1.24e-05	0.000103	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	1.23e-05	0.000103	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.23e-05	0.000102	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.22e-05	0.000102	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	1.21e-05	0.000101	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.21e-05	0.000101	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	1.21e-05	0.000101	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—NCOR1—polycystic ovary syndrome	1.19e-05	9.88e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	1.18e-05	9.85e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.18e-05	9.84e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.17e-05	9.79e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	1.17e-05	9.77e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	1.17e-05	9.75e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	1.17e-05	9.73e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.16e-05	9.67e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.16e-05	9.66e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PPARG—polycystic ovary syndrome	1.15e-05	9.61e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.14e-05	9.53e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.14e-05	9.49e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—POMC—polycystic ovary syndrome	1.14e-05	9.48e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	1.13e-05	9.44e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—INS—polycystic ovary syndrome	1.13e-05	9.42e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	1.13e-05	9.41e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	1.13e-05	9.4e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CYP1A1—polycystic ovary syndrome	1.12e-05	9.37e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PPARG—polycystic ovary syndrome	1.12e-05	9.35e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.11e-05	9.28e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	1.11e-05	9.24e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—POMC—polycystic ovary syndrome	1.11e-05	9.22e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	1.1e-05	9.2e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.1e-05	9.19e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—INS—polycystic ovary syndrome	1.1e-05	9.17e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.09e-05	9.05e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	1.08e-05	9.03e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	1.08e-05	8.99e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	1.08e-05	8.99e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.08e-05	8.98e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.08e-05	8.98e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	1.07e-05	8.92e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	1.07e-05	8.91e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.06e-05	8.86e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.06e-05	8.85e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.06e-05	8.82e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.05e-05	8.77e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—MTHFR—polycystic ovary syndrome	1.05e-05	8.73e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.05e-05	8.71e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	1.04e-05	8.71e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	1.02e-05	8.52e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.02e-05	8.5e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	1.01e-05	8.42e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	1.01e-05	8.39e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.01e-05	8.39e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	9.95e-06	8.29e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	9.92e-06	8.27e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.91e-06	8.26e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	9.83e-06	8.2e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	9.83e-06	8.19e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	9.67e-06	8.06e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	9.64e-06	8.04e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.62e-06	8.02e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	9.61e-06	8.01e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	9.6e-06	8e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	9.55e-06	7.96e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	9.53e-06	7.95e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	9.52e-06	7.94e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.48e-06	7.9e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	9.44e-06	7.87e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	9.43e-06	7.86e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—TH—polycystic ovary syndrome	9.39e-06	7.83e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	9.32e-06	7.77e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	9.26e-06	7.72e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	9.18e-06	7.65e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	9.13e-06	7.61e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	9.13e-06	7.61e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	9.02e-06	7.52e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	8.9e-06	7.42e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	8.88e-06	7.4e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	8.82e-06	7.35e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	8.8e-06	7.34e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	8.78e-06	7.32e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.77e-06	7.31e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	8.71e-06	7.26e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	8.67e-06	7.22e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.65e-06	7.21e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TH—polycystic ovary syndrome	8.61e-06	7.18e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	8.59e-06	7.16e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	8.56e-06	7.13e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PPARG—polycystic ovary syndrome	8.5e-06	7.08e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	8.4e-06	7e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—POMC—polycystic ovary syndrome	8.38e-06	6.99e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	8.37e-06	6.98e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—INS—polycystic ovary syndrome	8.33e-06	6.95e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	8.3e-06	6.92e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	8.22e-06	6.86e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	8.17e-06	6.81e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	8.16e-06	6.8e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	8.14e-06	6.78e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	8.1e-06	6.75e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	7.87e-06	6.56e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	7.84e-06	6.54e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	7.73e-06	6.44e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TH—polycystic ovary syndrome	7.68e-06	6.4e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	7.66e-06	6.39e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—POMC—polycystic ovary syndrome	7.62e-06	6.36e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—INS—polycystic ovary syndrome	7.58e-06	6.32e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	7.54e-06	6.28e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TH—polycystic ovary syndrome	7.5e-06	6.25e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.49e-06	6.25e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	7.47e-06	6.23e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	7.44e-06	6.2e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	7.44e-06	6.2e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.39e-06	6.16e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	7.3e-06	6.09e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	7.29e-06	6.08e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	7.27e-06	6.06e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TH—polycystic ovary syndrome	7.07e-06	5.89e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.05e-06	5.87e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	7.03e-06	5.86e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	7.03e-06	5.86e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	7.03e-06	5.86e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TH—polycystic ovary syndrome	7.01e-06	5.84e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	6.92e-06	5.77e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	6.87e-06	5.73e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	6.86e-06	5.72e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	6.81e-06	5.68e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	6.69e-06	5.58e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	6.48e-06	5.41e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	6.46e-06	5.39e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	6.45e-06	5.38e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	6.41e-06	5.34e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	6.35e-06	5.29e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.28e-06	5.23e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	6.27e-06	5.23e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	6.12e-06	5.1e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.05e-06	5.05e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TH—polycystic ovary syndrome	5.99e-06	4.99e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	5.98e-06	4.98e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	5.92e-06	4.93e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	5.83e-06	4.86e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	5.82e-06	4.85e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.82e-06	4.85e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	5.77e-06	4.81e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.74e-06	4.79e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	5.72e-06	4.77e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	5.66e-06	4.72e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	5.53e-06	4.61e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	5.5e-06	4.58e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	5.48e-06	4.56e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	5.45e-06	4.54e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.42e-06	4.52e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.34e-06	4.45e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	5.28e-06	4.4e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	5.23e-06	4.36e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	5.21e-06	4.34e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	5.16e-06	4.31e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	5.16e-06	4.3e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	5.15e-06	4.3e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—INS—polycystic ovary syndrome	5.13e-06	4.28e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	4.89e-06	4.07e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	4.86e-06	4.05e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	4.81e-06	4.01e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	4.8e-06	4e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	4.73e-06	3.94e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—INS—polycystic ovary syndrome	4.71e-06	3.92e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	4.66e-06	3.88e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.62e-06	3.85e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.49e-06	3.75e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	4.41e-06	3.68e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	4.28e-06	3.57e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.23e-06	3.52e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	4.22e-06	3.52e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—INS—polycystic ovary syndrome	4.2e-06	3.5e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.18e-06	3.48e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.12e-06	3.44e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	4.11e-06	3.43e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.1e-06	3.42e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	3.94e-06	3.28e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	3.9e-06	3.25e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	3.88e-06	3.24e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.86e-06	3.22e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	3.85e-06	3.21e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—INS—polycystic ovary syndrome	3.83e-06	3.19e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.77e-06	3.14e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.59e-06	3e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.41e-06	2.84e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	3.34e-06	2.78e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	3.29e-06	2.74e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—INS—polycystic ovary syndrome	3.27e-06	2.73e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.18e-06	2.65e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.57e-06	2.15e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.54e-06	2.12e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.53e-06	2.11e-05	CbGpPWpGaD
